STERIS is pleased to announce that it has been accepted to participate in the U.S. Food and Drug Administration (FDA) Ethylene Oxide Sterilization Master File Pilot Program (Pilot Program), first announced by the FDA in 2019.
Details
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the expansion of its existing Brooklyn Park, Minnesota, USA laboratory to include product and packaging testing services.
Details
Earlier this year, STERIS announced the addition of X-ray sterilization services at our Venlo, The Netherlands facility. As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Venlo, The Netherlands facility has now received its updated ISO 13485 accreditation to include X-ray processing.
Details
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Libertyville, Illinois, USA laboratory is now ISO 17025 accredited.
Details
Earlier this year, STERIS announced the addition of electron beam testing services at our Radiation Technology Center (RTC) in Libertyville, Illinois, USA. We are now excited to announce the addition of X-ray testing services, which completes the expansion of this dedicated facility. The expansion to include X-ray testing services complements our existing gamma and…
Details
STERIS is pleased to announce the completed expansion of its existing Bradford, UK gamma processing site to include a dedicated Radiation Technology Centre (RTC), specializing in the processing of non-routine samples. The RTC provides a state-of-the-art, streamlined service through: Equipment capabilities: turntables with adjustable dose rates adjacent to a precision, optimized cobalt-60 source Processing methodologies: specialized operational qualification…
Details